Company Overview - Century Therapeutics (NASDAQ: IPSC) is focused on developing induced pluripotent stem cell (iPSC)-derived cell therapies aimed at treating cancer and autoimmune diseases, addressing limitations of first-generation cell therapies [2] - The company utilizes adult stem cells and aims to create curative cell therapy products that specifically target hematologic and solid tumor cancers, with potential applications in autoimmune diseases [2] - Century Therapeutics is leveraging expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies that could provide significant advantages over existing cell therapy technologies [2] Upcoming Events - Members of the management team will participate in the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024, with a panel discussion on autoimmune disease cell therapy scheduled for 3:00 PM ET [1] - A fireside chat featuring the CEO and Chief Scientific Officer will take place at 4:30 PM ET, with a live webcast available on the company's website [1] - A replay of the webcast will be accessible for 90 days following the event [1]
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference